These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35265762)

  • 1. Relationship of brain edema after deep brain stimulation surgery with motor and cognitive function.
    Nishiguchi Y; Matsuura K; Hirata Y; Mizutani A; Katoh N; Ishikawa H; Miyashita K; Utsunomiya T; Kajikawa H; Nishikawa H; Araki T; Shindo A; Tomimoto H
    Heliyon; 2022 Feb; 8(2):e08900. PubMed ID: 35265762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do patient's get angrier following STN, GPi, and thalamic deep brain stimulation.
    Burdick AP; Foote KD; Wu S; Bowers D; Zeilman P; Jacobson CE; Ward HE; Okun MS
    Neuroimage; 2011 Jan; 54 Suppl 1():S227-32. PubMed ID: 20932923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subthalamic nucleus deep brain stimulation does not improve visuo-motor impairment in Parkinson's disease.
    Israeli-Korn SD; Hocherman S; Hassin-Baer S; Cohen OS; Inzelberg R
    PLoS One; 2013; 8(6):e65270. PubMed ID: 23776460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric complications and neuroimaging characteristics after deep brain stimulation surgery for Parkinson's disease.
    Radziunas A; Deltuva VP; Tamasauskas A; Gleizniene R; Pranckeviciene A; Surkiene D; Bunevicius A
    Brain Imaging Behav; 2020 Feb; 14(1):62-71. PubMed ID: 30267364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary.
    Rughani A; Schwalb JM; Sidiropoulos C; Pilitsis J; Ramirez-Zamora A; Sweet JA; Mittal S; Espay AJ; Martinez JG; Abosch A; Eskandar E; Gross R; Alterman R; Hamani C
    Neurosurgery; 2018 Jun; 82(6):753-756. PubMed ID: 29538685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The white matter hyperintensities within the cholinergic pathways and cognitive performance in patients with Parkinson's disease after bilateral STN DBS.
    Liu Y; Wu L; Yang C; Xian W; Zheng Y; Zhang C; Hong G; Jiang L; Yang Z; Pei Z; Liu J; Chen L
    J Neurol Sci; 2020 Nov; 418():117121. PubMed ID: 32950863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric Symptoms in Parkinson's Disease After Subthalamic Nucleus Deep Brain Stimulation.
    Liu W; Yamamoto T; Yamanaka Y; Asahina M; Uchiyama T; Hirano S; Shimizu K; Higuchi Y; Kuwabara S
    Front Neurol; 2021; 12():656041. PubMed ID: 34017303
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuropsychological and psychiatric assessments following bilateral deep brain stimulation of the subthalamic nucleus in Japanese patients with Parkinson's disease.
    Aono M; Iga J; Ueno S; Agawa M; Tsuda T; Ohmori T
    J Clin Neurosci; 2014 Sep; 21(9):1595-8. PubMed ID: 24794694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep brain stimulation and cognitive decline in Parkinson's disease: The predictive value of electroencephalography.
    Markser A; Maier F; Lewis CJ; Dembek TA; Pedrosa D; Eggers C; Timmermann L; Kalbe E; Fink GR; Burghaus L
    J Neurol; 2015 Oct; 262(10):2275-84. PubMed ID: 26159102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term follow-up on quality of life and its relationship to motor and cognitive functions in Parkinson's disease after deep brain stimulation.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Weibing L; Kuwabara S
    J Neurol Sci; 2017 Aug; 379():18-21. PubMed ID: 28716237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does post-operative symptomatic lead edema associated with subthalamic DBS implantation impact long-term clinical outcomes?
    Sharma VD; Lyons KE; Nazzaro JM; Pahwa R
    J Neurol Sci; 2020 Mar; 410():116647. PubMed ID: 31901593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longterm outcome of cognition, affective state, and quality of life following subthalamic deep brain stimulation in Parkinson's disease.
    Gruber D; Calmbach L; Kühn AA; Krause P; Kopp UA; Schneider GH; Kupsch A
    J Neural Transm (Vienna); 2019 Mar; 126(3):309-318. PubMed ID: 30684055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease.
    Mueller K; Jech R; Růžička F; Holiga Š; Ballarini T; Bezdicek O; Möller HE; Vymazal J; Růžička E; Schroeter ML; Urgošík D
    Neuroimage Clin; 2018; 19():1025-1035. PubMed ID: 30035027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic, non-infectious, non-hemorrhagic edema after subthalamic nucleus deep brain stimulation surgery for Parkinson's disease.
    Nazzaro JM; Pahwa R; Lyons KE
    J Neurol Sci; 2017 Dec; 383():42-46. PubMed ID: 29246619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of white matter lesions on the cognitive outcome of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Blume J; Lange M; Rothenfusser E; Doenitz C; Bogdahn U; Brawanski A; Schlaier J
    Clin Neurol Neurosurg; 2017 Aug; 159():87-92. PubMed ID: 28582689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subthalamic Stimulation for Camptocormia in Parkinson's Disease: Association of Volume of Tissue Activated and Structural Connectivity with Clinical Effectiveness.
    Lai Y; Song Y; Huang P; Wang T; Wang L; Pan Y; Sun Q; Sun B; Zhang C; Li D
    J Parkinsons Dis; 2021; 11(1):199-210. PubMed ID: 33325395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term cognitive outcome of bilateral subthalamic deep brain stimulation in Parkinson's disease.
    Kim HJ; Jeon BS; Paek SH; Lee KM; Kim JY; Lee JY; Kim HJ; Yun JY; Kim YE; Yang HJ; Ehm G
    J Neurol; 2014 Jun; 261(6):1090-6. PubMed ID: 24687897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutations.
    Mangone G; Bekadar S; Cormier-Dequaire F; Tahiri K; Welaratne A; Czernecki V; Pineau F; Karachi C; Castrioto A; Durif F; Tranchant C; Devos D; Thobois S; Meissner WG; Navarro MS; Cornu P; Lesage S; Brice A; Welter ML; Corvol JC;
    Parkinsonism Relat Disord; 2020 Jul; 76():56-62. PubMed ID: 32866938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.